21 - 22 May 2020

5th Annual MarketsandMarkets Epigenetics- Digital Conference ( Time Zone - CENTRAL EUROPEAN TIME (CET)

In recent years, the understanding regarding the role of epigenetic factors has been improved. Epigenetic research has been generally determined by technological advancement, remarkably high-throughput sequencing technologies. In spite of the fact that technologies have been improved and have been responsible for the advances in the field, several challenges remain.

Our 5th Annual Epigenetics- Digital Conference will discuss the solutions to challenges like, drug discovery, identification of molecular inhibitors, gene modification and analysis.

The digital conference is scheduled on 21st & 22nd May 2020, which is one of the unique platform discussing about epigenetics based clinical development and combinational therapies, with a special emphasis on transcriptional analysis and molecular profiling.

WHAT TO EXPECT
Key Highlights
  • Epigenetic modification
  • Genomic profiling
  • Transcriptional mechanism
  • Molecular inhibitors
  • Epigenetic modulators
  • Clinical applications of epigenetics
Who should attend?

Heads, Directors, Group Leaders, Professors, Lecturers, Research Associates, Scientists, Investigators, Fellows, Readers from Pharmaceutical, Bio-pharmaceutical and Research Institutes working in:

  • Epigenetics
  • Developmental Epigenetics
  • Epidemiology
  • Molecular Biology
  • Developmental Biology
  • Biological Sciences
  • Biochemistry
  • Medicinal Chemistry
  • Pharmaceutical chemistry
  • Genetics and Genomics
  • Developmental Genetics
  • Translational sciences/medicines
CONFERENCE AGENDA
CONFERENCE SPEAKERS
Advisors
Gavin Reynolds

Gavin Reynolds

Professor Emeritus
Queens University Belfast

Gavin Reynolds

Professor Emeritus
Queens University Belfast
Alfredo Budillon

Alfredo Budillon

Chief Experimental Pharmacology Unit Department of
Istituto Nazionale tumori G. Pascale

Alfredo Budillon

Chief Experimental Pharmacology Unit Department of
Istituto Nazionale tumori G. Pascale
Speakers
Gavin Reynolds

Gavin Reynolds

Professor Emeritus
Queens University Belfast

Gavin Reynolds

Professor Emeritus
Queens University Belfast
Alfredo Budillon

Alfredo Budillon

Chief Experimental Pharmacology Unit Department of
Istituto Nazionale tumori G. Pascale

Alfredo Budillon

Chief Experimental Pharmacology Unit Department of
Istituto Nazionale tumori G. Pascale
Dr Jane Cleal

Dr Jane Cleal

Lecturer in Epigenetics
University of Southampton

Dr Jane Cleal

Lecturer in Epigenetics
University of Southampton
Desiree Goubert

Desiree Goubert

University of Groningen
Faculty of MedicalSciences

Desiree Goubert

University of Groningen
Faculty of MedicalSciences
Rab Prinjha

Rab Prinjha

VP Head of Adaptive Immunity RU, Research
GSK

Rab Prinjha

VP Head of Adaptive Immunity RU, Research
GSK
Marcus Buschbeck

Marcus Buschbeck

Group Leader
Josep Carreras Leukaemia Institute

Marcus Buschbeck

Group Leader
Josep Carreras Leukaemia Institute
William M Brown

William M Brown

Senior Lecturer in Psychology
University of Bedfordshire

William M Brown

Senior Lecturer in Psychology
University of Bedfordshire
Angela Garding

Angela Garding

Field Application Scientist
Covaris

Angela Garding

Field Application Scientist
Covaris
SPONSORS
Speaking Partner
example-image

Covaris, Inc.

example-image

Active Motif

Leading Partner
example-image

PerkinElmer

PARTNERS
Supporting Association
MediWales

MediWales

BioAlps

BioAlps

Epigenetics Society

Epigenetics Society

PAST EVENT GALLERY